GLP-1 Receptor Agonists Improve Glycemic, Weight Outcomes in Children With T2D

TUESDAY, Sept. 23, 2025 (HealthDay News) -- In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1